Relevant studies revealed that SIRT5 can promote autophagy of gastric cancer cells, and SIRT5 can inhibit peroxisome-induced oxidative stress, thus protecting the liver and inhibiting the development of hepatoma cells (Chen et al., 2018; Gu et al., 2021). Here, SIRT5 is linked to hepatocellular carcinoma.